Altered metabolism of lipids is currently considered a hallmark characteristic of many
malignancies, including colorectal cancer (CRC). Lipids are a large group of metabolites …

Background: Colorectal cancer (CRC) represents a third leading cause of cancer-related
death worldwide. The reliable diagnostic biomarkers for detecting CRC at early stage is …

Background: Metabolic and transcriptomic differences between visceral adipose tissue
(VAT) and subcutaneous adipose tissue (SAT) compartments, particularly in the context of …

Diet composition may affect the onset and progression of chronic degenerative diseases,
including cancer, whose pathogenesis relies on inflammatory processes. Growing evidence …

Background: Unlike experimental results, epidemiologic studies that used dietary
questionnaires were not convincing as regards the relations between dietary fatty acids …

Purpose Although trans fatty acid has been associated with diabetes and cardiovascular
disorders, studies gave conflicting results when examined their impact on colorectal cancer …

Colorectal cancer (CRC) is among the major threatening diseases worldwide, being the
third most common cancer, and a leading cause of death, with a global incidence expected …

Background. T cell‐mediated antitumor immune response is the basis of colorectal cancer
(CRC) immunotherapy. Cholesterol plays an important role in T cell signal transduction and …

Background We aimed to identify plasma and urinary metabolites related to colorectal
cancer (CRC) risk and elucidate their mediator role in the associations between modifiable …

Background Several prospective cohort and case-control studies reported the inconsistent
association between biospecimen composition of C20 and C22 long-chain (LC) n-3 …